A Comperative Study on Health Sector in South Asia and Middle East Countries (Clinical Trial Studies)

  • Said Alavi Kolambil Institute of Pharmacy, Shri Jagdishprasad Jhabarmal Tibrewala Uinversity Vidya Nagari, Chudela Jhunjhunu, India
  • Rakesh Kumar Jat Institute of Pharmacy, Shri Jagdishprasad Jhabarmal Tibrewala Uinversity Vidya Nagari, Chudela Jhunjhunu, India

Abstract

Pharmaceutical industries found suitable option in conducting clinical trial in  south Asia  and Middle East countries due less cost compare to western countries, pool of patient, and supported by highly infrastructural hospital, well trained staffs, liberalized policy of the concerned government.  (E.g. in India), however once the products were succeeded, it denied access to the common man in affordable rate. the studies conducted on 463 participant from the region of middle east and from south Asian countries This studies revealed that there is a positive and highly correlation on fraudulent activities in clinical trial due to lack of ethical obligation and professional standards and on by scarcity of state and local law, shortage of tracking facility which encouraged this nefarious situation, even for the lawsuits, victim worried to comes forward.


Keywords: Clinical Trial, Quality of Life, Middle East and south Asian countries

Downloads

Download data is not yet available.

References

1. Hilal Ilbars. Hamdi Akan (2014) Orphan Drugs: R&D Challenges With Updates from Turkey and Middle East Countries.58 Journal of Clinical Studies 6(2) 68-63.
2. Benatar Sr, Singer Pa Et Al (2000) A New Look at International Research Ethics. BMJ; 321(7264):824-6.
3. Annas, George J (2009). ‘Globalized Clinical Trials and Informed Consent’, New England Journal of Medicine. 360:2050-2053.
4. Peter C Gotsche (2009) What Should Be Done To Tackle Ghost Writing In The Medical Literature? Plos Medicine.6 (2).
5. Aslam A, Imanullah S, and Ayman El-Menyar (2013) Registration Of Clinical Trial: Is It Really Needed? North American Journal of Medical Sciences.5 (12):713-715.
6. Chan et al (2013) Defining Standard Protocol Items for Clinical Trials Research and Reporting Methods Annals of Internal Medicine, 158(3):201-207.
7. Sisira Siribaddana (2013) Clinical Trials in Sri Lanka: New Act at the Behest of Pharmaceutical Industry Indian Journal of Medical Ethics 9(4).
8. Waheed S, Siddiqui E (2013) “The unseen and untold issues of clinical trials and research ethics in Pakistan” International Journal of Medicine and Biomedical Research 2(2).161-162.
9. Halidou Tinto, Ramadhani A.Noor (2013), Good Clinical Practice In Resource-Limited Settings: Translating Theory In To Practice The American Journal Of Tropical Medicine And Hygiene 88(4):608-613.
10. Nida Khan., (2014). “The Post Research Ethical Obligation of Research Enterprise in Developing Countries” Journal of Clinical Research and Bioethics 4(5) 1-5
Statistics
253 Views | 157 Downloads
How to Cite
1.
Kolambil SA, Jat RK. A Comperative Study on Health Sector in South Asia and Middle East Countries (Clinical Trial Studies). JDDT [Internet]. 19Dec.2019 [cited 14Jun.2021];9(4-s):1101-6. Available from: https://jddtonline.info/index.php/jddt/article/view/3792